The Latest Breaking News from Baird

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

This Cathie Wood stock just received an upgrade from an analyst who recommends it for long-term investors.

The billionaire investor takes a sizable position in this healthcare services provider.

Cencora has underperformed the broader market over the past year, and Wall Street analysts appear moderately bullish about the stock’s future.

Taser maker Axon earnings surged 42%. Sales grew 32% for the potential Donald Trump beneficiary.

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed unchanged, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.54%. Stocks on Thursday extended their post-election rally, with the S&P 500, the Dow Jones Industrials,...

One of the nation's biggest used car dealers appears to turn a corner.

With Warren Buffett’s dividend-paying favorite pulling back after a mixed Q3 earnings release, should investors consider buying AXP stock?

Elevance Health stock is plunging Thursday after the insurer missed Q3 earnings expectations and lowered its full-year outlook. Here's what you need to know.

This underperforming AI stock just received an upgrade, and is extending its run into positive territory for 2024.

Here’s what could be next for the EV maker.